| 
March 14, 2023
A quick look at yesterday: an influx of buyers helped the US-German healthcare company to end the session higher around $19.81, while establishing a $19.77 to $20.05 session range yesterday.
United States Consumer Price Index is next today at 12:30 UTC.
Meanwhile, United States Participation Rate (Feb) released yesterday at 13:30 UTC with a figure of 118.3, while the previous figure was 62.4.
Chart analysis suggests although Fresenius Medical Care AG & Co. KGaA is appreciating today after rising as high as $20.05, price action is now slowing and consolidating around 17 cents below the $20 resistance level.
This rally in Fresenius Medical Care's share price coincided with other health care stocks as Eli Lilly and Company traded at $324.49 after closing yesterday's trading day at $315 (up 3%). Amgen traded at $233.18 after closing yesterday's trading day at $227.87 (up 2.33%).
Fresenius Medical Care went up yesterday, yet these health care stocks did not follow — Merck lost 1.82% yesterday and closed at $105.73.
Also worthy of note, United States Retail Sales projected to decline to -0.3% while previous data was 3%; data will be released tomorrow at 12:30 UTC. As things stand, upcoming United States Core Retail Sales data is projected to fall short of market expectations with newly published data of -0.1%, following on from the preceding figure of 2.3%. New data is set to be published tomorrow at 12:30 UTC. United States Producer Price Index projected to come out at 0.3% — worse than previous data of 0.7%; data will be released tomorrow at 12:30 UTC.
This year has been a bright one for the US-German healthcare company after trading as low as $12.81 and going on to appreciate by 23.36% year to date.
